Neothetics (NEOT) Prices Upsized IPO at $14, Middle of Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Neothetics Prices Initial Public Offering
November 19, 2014 7:35 PM ESTSAN DIEGO, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq: NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the pricing of its initial public offering of 4,650,000 shares of its common stock at a public offering price of $14.00 per share. In addition, Neothetics has granted the underwriters a 30-day option to purchase up to an additional 697,500 shares of common stock at the same price to cover over-allotments, if any. All shares of the common stock in this offering are being sold by Neothetics. The shares are scheduled to... More
